Karyopharm Therapeutics (25K0) Cash flow

1 Followers

Karyopharm Therapeutics Cash Flow

DE:25K0's free cash flow for Q2 2026 was $-24.93M. For the 2026 fiscal year, DE:25K0's free cash flow was decreased by $52.26M and operating cash flow was $-24.93M. See a summary of the company’s cash flow.

Cash Flow	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Operating Cash Flow	$ -75.37M	$ -127.49M	$ -92.72M	$ -149.55M	$ -107.12M
Investing Cash Flow	$ 43.38M	$ 95.47M	$ 7.94M	$ -104.26M	$ 141.84M
Financing Cash Flow	$ 30.05M	$ 41.65M	$ 1.12M	$ 193.74M	$ 73.65M
End Cash Position	$ 60.89M	$ 62.81M	$ 53.19M	$ 136.88M	$ 197.44M
Free Cash Flow	$ -75.37M	$ -127.63M	$ -92.72M	$ -149.67M	$ -112.83M

Currency in USD